News

Zevra Therapeutics to Report First Quarter 2023 Results on May 15, 2023

CELEBRATION, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company, formerly KemPharm, Inc.),…

2 years ago

Cronos Group Reports 2023 First Quarter Results

Industry-leading balance sheet with $836 million in cash and short-term investments Targeting positive cash flow in 2024 Net revenue in…

2 years ago

Anavex Life Sciences Reports Fiscal 2023 Second Quarter Financial Results

Newly available preliminary efficacy results of surrogate biomarkers from the ANAVEX®2-73-AD-004 study; allowing initiation of discussions with regulatory agencies for…

2 years ago

Neuronetics Reports Record First Quarter 2023 Financial and Operating Results

MALVERN, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “company” or Neuronetics”) a commercial stage medical technology…

2 years ago

Sensei Biotherapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights

- Investigational New Drug (IND) application for SNS-101 cleared by U.S. Food and Drug Administration (FDA) with first patient dose…

2 years ago

Vivos Therapeutics Announces Additional Strategic Initiatives Aimed at Accelerating Anticipated Timeline for Cash Flow Positive Operations

Moss Adams LLP also appointed as new independent registered public accounting firmLITTLETON, Colo., May 09, 2023 (GLOBE NEWSWIRE) -- Vivos…

2 years ago

Prominent New York Internist Collaborates with Castle Connolly Private Health Partners, LLC to Join a Concierge Medical Program that Offers a Personalized Approach to Patient Care

Dr. Claire Binsol Prominent New York Internist Collaborates with Castle Connolly Private Health Partners, LLC to Join a Concierge Medical…

2 years ago

Biora Therapeutics to Report First Quarter 2023 Financial Results and Provide Corporate Update

SAN DIEGO, May 08, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic…

2 years ago

ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer’s Disease

TORONTO, Ontario and CAMBRIDGE, Massachusetts, May 08, 2023 (GLOBE NEWSWIRE) -- In preclinical studies, PMN310 demonstrated the ability to selectively…

2 years ago

Be The Match Champions Raise Over $420,000 at 2023 New York Gala to Save More Lives Through Blood Stem Cell Transplants

NY Times Bestselling Author and Transplant Recipient Suleika Jaouad Honored with Inaugural INSPIRE Award and Amazon Web Services Awarded for…

2 years ago